恶唑啉|Oxazolines-毕得医药

关于我们|联系我们 400-600-5915|sales@picasso-e.com

登录 | 注册批量下单

搜索购物车会员中心

恶唑啉是一种含氧原子和氮原子的五元杂环化合物。它可能最早合成于1884年，但直到5年后，西格蒙·加布里埃尔才正确地指定了这种结构。它与Hantzsch–Widman命名法一致，是一族杂环化合物的一部分，在饱和度方面它存在于噁唑和噁唑烷之间。

按化学元素: B^x; C^x; N^x; O^x; F^x; Si^x; P^x; S^x; Cl^x; Br^x; I^x

母核：

官能团： 酯 (2) 芳基 (7) 酰胺 (1)

按纯度： 99+% 99% 98+% 98% 97+% 97% 96+% 96% 95+% 95% 93% 90+% 90%

按分子量： 0-100 100-200 200-300 300-400 400-500 500-600

按化学元素： CINO CNOSSi CNOP CClFNO CINOS CBrNO CFINO CNOSi CClNOS COS CNO CNOS CNOSe CFNOS CBrKNO CClFNOS CBrNOS CBrClNO CClNO CBrFNO CBrNOSe CFNO CFNOSe CBNO 更多

4-(ethoxymethylene)-2-phenyloxazol-5(4H)-one 4-(乙氧基亚甲基)-2-苯基恶唑-5(4H)-酮: BJS771837715646-46-595%; ￥158.00250mg

2,6-Bis((S)-4-isopropyl-4,5-dihydrooxazol-2-yl)pyridine 2,6-二[(4S)-4-异丙基-2-噁唑啉基]吡啶: BJS3893557118949-61-498% 99%ee; ￥323.001g

(S)-4-(tert-Butyl)-2-(6-methylpyridin-2-yl)-4,5-dihydrooxazole (S)-4-(叔丁基)-2-(6-甲基吡啶-2-基)-4,5-二氢恶唑: BJS0307766199277-80-097%; ￥630.00100mg

1,3-Bis((S)-4-((S)-sec-butyl)-4,5-dihydrooxazol-2-yl)benzene 1,3-双((S)-4-((S)-仲丁基)-4,5-二氢恶唑-2-基)苯: BJS7221695131380-86-498%; ￥10599.001g

(S)-4-Isopropyl-2-(5-(trifluoromethyl)pyridin-2-yl)-4,5-dihydrooxazole (S)-4-异丙基-2-(5-(三氟甲基)吡啶-2-基)-4,5-二氢噁唑: BJS93679241803416-30-998%; ￥256.00100mg

(3aR,8aS)-2-(4-(Trifluoromethyl)pyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole (3aR,8aS)-2-(4-(三氟甲基)吡啶-2-基)-3a,8a-二氢-8H-茚并[1,2-d]噁唑: BJS33359822126903-00-097% 99%ee; ￥1495.00250mg

(R)-2-(6-Benzhydrylpyridin-2-yl)-4-(tert-butyl)-4,5-dihydrooxazole (R)-2-(6-二苯甲基吡啶-2-基)-4-(叔丁基)-4,5-二氢恶唑: BJS45469262757083-50-297% 99%ee; ￥2447.00100mg

(4S,4'S)-2,2'-(1-Phenylpropane-2,2-diyl)bis(4-isopropyl-4,5-dihydrooxazole) (4S,4'S)-2,2'-(1-苯基丙烷-2,2-二基)双(4-异丙基-4,5-二氢恶唑): BJS9325553698350-53-797%; ￥462.00100mg

(S)-4-Benzyl-2-(4-methoxy-6-methylpyridin-2-yl)-4,5-dihydrooxazole (S)-4-苄基-2-(4-甲氧基-6-甲基吡啶-2-基)-4,5-二氢噁唑: BJS08828642757082-40-798%; ￥498.00100mg

(4S)-4-(sec-Butyl)-2-(pyridin-2-yl)-4,5-dihydrooxazole (4S)-4-(仲丁基)-2-(吡啶-2-基)-4,5-二氢恶唑: BJS73091451620588-66-098%; ￥708.00100mg

(4S,4'S)-2,2'-(2-(4-(tert-Butyl)phenyl)ethane-1,1-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole) (4S,4'S)-2,2'-(2-(4-(叔丁基)苯基)乙烷-1,1-二基)双(4-(叔丁基)-4,5-二氢恶唑): BJS64288862634687-80-098%; ￥515.00100mg

2,2-Bis((R)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)acetonitrile 2,2-双((R)-4-(叔丁基)-4,5-二氢恶唑-2-基)乙腈: BJS18389611442644-13-497%; ￥3669.00250mg

(4R,5S)-2-(6-Methylpyridin-2-yl)-4,5-diphenyl-4,5-dihydrooxazole (4R,5S)-2-(6-甲基吡啶-2-基)-4,5-二苯基-4,5-二氢恶唑: BJS18306532417321-37-897% 99%ee; ￥1520.00100mg

(R)-2-(5-Chloropyridin-2-yl)-4-isopropyl-4,5-dihydrooxazole (R)-2-(5-氯吡啶-2-基)-4-异丙基-4,5-二氢恶唑: BJS32668582757083-23-997% 99%ee; ￥9635.001g

(R)-4-Benzyl-2-(5-bromopyridin-2-yl)-4,5-dihydrooxazole (R)-4-苄基-2-(5-溴吡啶-2-基)-4,5-二氢恶唑: BJS94634802757083-32-097% 99%ee; ￥2203.00250mg

2-(Pyridin-2-ylmethyl)-4,5-dihydrooxazole 2-(吡啶-2-基甲基)-4,5-二氢恶唑: BJS76920172757085-39-397%; ￥2029.00100mg

7-Bromo-2-methyl-2,3-dihydropyrazolo[5,1-b]oxazole 7-溴-2-甲基-2,3-二氢吡唑并[5,1-b]恶唑: BJS05199822676861-81-597%; ￥16170.001g

(S)-2-(Benzo[b]thiophen-2-yl)-4-ethyl-4,5-dihydrooxazole (S)-2-(苯并[b]噻吩-2-基)-4-乙基-4,5-二氢恶唑: BJS24369622828438-80-697%; ￥779.00100mg

(R)-2-(Benzo[b]thiophen-2-yl)-4-ethyl-4,5-dihydrooxazole (R)-2-(苯并[b]噻吩-2-基)-4-乙基-4,5-二氢恶唑: BJS14135112828438-81-797%; ￥779.00100mg

(S)-2-(Benzo[b]thiophen-2-yl)-4-methyl-4,5-dihydrooxazole (S)-2-(苯并[b]噻吩-2-基)-4-甲基-4,5-二氢恶唑: BJS37057122828439-74-198%; ￥632.00100mg

1 2 3 4 5 6 7 8 9 ... 16